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Abstract
In the genomic era, the identification of gene signatures associated with disease is
of significant interest. Such signatures are often used to predict clinical outcomes in
new patients and aid clinical decision-making. However, recent studies have shown
that gene signatures are often not replicable. This occurrence has practical implica-
tions regarding the generalizability and clinical applicability of such signatures. To
improve replicability, we introduce a novel approach to select gene signatures from
multiple datasets whose effects are consistently non-zero and account for between-
study heterogeneity. We build our model upon some rank-based quantities, facil-
itating integration over different genomic datasets. A high dimensional penalized
Generalized Linear Mixed Model (pGLMM) is used to select gene signatures and ad-
dress data heterogeneity. We compare our method to some commonly used strategies
that select gene signatures ignoring between-study heterogeneity. We provide asymp-
totic results justifying the performance of our method and demonstrate its advantage
in the presence of heterogeneity through thorough simulation studies. Lastly, we mo-
tivate our method through a case study subtyping pancreatic cancer patients from
four gene expression studies.
Keywords: Generalized linear mixed models, microarray, penalized likelihood, prediction,
RNA-seq.
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1 Introduction
In the genomic era, gene signatures are often utilized to subtype cancer patients, determine
treatment, and predict response to therapy (Golub et al., 1999; Swisher et al., 2012; Sotiriou
and Piccart, 2007). Such signatures are defined as the collection of one or more genes whose
expression has validated specificity with respect to a particular clinical outcome (Chibon,
2013). These signatures are often incorporated into statistical or computational models for
predicting clinical outcome in future patients. For these reasons, gene signature selection
and subsequent clinical prediction is of significant interest in cancer research.
However, several problems exist with the application of such signatures. For example,
inconsistency in gene signature selection is common in published biomedical articles. Gene
signatures identified in one article often show little or even no overlap with the ones identi-
fied in another article (Waldron et al., 2014). In addition, models based upon these signa-
tures have shown variable accuracy in predicting outcomes in new clinical studies (Sotiriou
and Piccart, 2007; Waldron et al., 2014), or estimate contradictory effects of individual
genes (Swisher et al., 2012). This lack of replicability presents natural questions towards
the generalizability and reliability of utilizing such gene signatures for clinical prediction
(Sotiriou and Piccart, 2007).
A number of factors contribute to such a lack of replicability. For example, studies
with small sample size have been shown to lack power in selecting gene signatures (Sotiriou
and Piccart, 2007) and have low prediction accuracy in new studies (Waldron et al., 2014).
Variation in the prevalence of the clinical outcome also affects replicability. Lusa et al.
(2007) demonstrate that gene signatures derived from studies with low frequencies of certain
molecular subtypes are less likely to accurately predict molecular subtype in new patients.
Study-specific factors such as variation in laboratory conditions or clinical protocols may
also introduce additional variation in the effects of individual genes.
Differences in data pre-processing is another source. For example, the prediction ac-
curacy of certain classifiers has been shown to be sensitive to the type of normalization
method in the pre-processing step (Lusa et al., 2007; Paquet and Hallett, 2015). New
datasets must be normalized to the training data prior to its application for prediction to
correct for technical biases. However, prior work has shown that this procedure results in
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“test-set bias”, where predictions may change due to the samples in the test set or the
normalization approach used (Patil et al., 2015). Sophisticated procedures have been de-
veloped for microarrays to avoid test-set bias, but still require expression data to come from
the same type of microarray chip (McCall et al., 2010). If the new study utilizes a different
platform, it is even harder to apply and validate the prediction model. For example, next
generation sequencing data measures gene expression on a different scale (positive integer
counts) relative to microarray data (continuous measurements). Such a difference typically
makes methods developed for one platform not applicable to the other (Glas et al., 2006).
To improve replicability, various statistical methods have been developed to integrate
data from multiple studies (horizontal integration) to reach a consensus conclusion. Richard-
son et al. (2016) give a comprehensive review of recent developments in this field. Address-
ing between-study heterogeneity is critical in horizontal data integration, as data from
different studies come from different cohorts, platforms and bio-samples. Several methods
(Li et al., 2011, 2014) have been developed to account for between-study heterogeneity in
horizontal data integration. However, these methods mainly focus on variable selection
instead of prediction.
Motivated by a case study in subtyping pancreatic cancer patients, we develop a new
horizontal integration method that selects gene signatures from multiple datasets and ac-
counts for between-study heterogeneity in variable effects. We apply a rank-based trans-
formation based upon gene pairs to the raw expression data, facilitating data integration
from multiple studies. We note that some care needs to be taken when merging data from
different expression platforms. More details of this rank-based transformation will be dis-
cussed in Section 3. Given the transformed data, we utilize a penalized Generalized Linear
Mixed Model (pGLMM) to select predictors with study-replicable effects and account for
between-study heterogeneity. In particular, we assume the effect of each predictor to be
random among different studies. We design a penalty function to select predictors with
nonzero fixed effects in addition to those with non-zero variance across studies. We propose
to only use predictors with nonzero fixed effects to predict outcome in new subjects, as their
effects are replicable in multiple studies. Through simulation and case studies, we demon-
strate that in the presence of between-study heterogeneity, our proposed method can result
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in better prediction performance than other commonly used strategies, especially when
the heterogeneity is large. Moreover, as we use the transformed data as predictors in the
pGLMM, our method aims to select gene pairs instead of individual genes for prediction.
2 Data
Pancreatic Ductal Adenocarcinoma (PDAC) remains a lethal disease with a 5-year survival
rate of 4%. A key hallmark of PDAC is the low tumor cellularity of patient samples, which
makes capturing precise tumor-specific molecular information difficult. Due to this fact,
genomic subtyping of PDAC to inform treatment selection has been limited.
In a recent study, Moffitt et al. (2015) identified genes that are expressed solely in
pancreatic tumor cells. Based upon these tumor-specific genes, two novel tumor subtypes
(‘basal-like’ and ‘classical’) were identified and validated. Subtypes were found to be prog-
nostic, in that patients with basal-like tumors had significantly worse median survival than
patients with classical tumors. Lastly, it was found that tumor-specific genes from the
basal-like subtype also define a similar basal-like subtype in breast and bladder cancers,
suggesting a common basal-like genomic profile shared across cancer types. This study rep-
resented the largest investigation of primary and metastatic PDAC gene expression thus
far and provided new insights into the molecular composition of PDAC. These insights may
be used to make tailored treatment recommendations.
Given these promising results, methods are needed to robustly predict basal-like sub-
type. However, existing datasets with basal-like subtypes in PDAC are limited. Therefore,
we utilize the gene expression data from Moffitt et al. (2015) in addition to recently pub-
lished PDAC RNA-seq data to train a PDAC subtype classifier. Of the three datasets
examined in Moffitt et al. (2015), two are single-channel microarrays (UNC PDAC, UNC
Breast Cancer) and one is RNA-seq (TCGA Bladder Cancer). Since the publication of
Moffitt et al. (2015), an additional PDAC RNA-seq dataset from The Cancer Genome At-
las (TCGA) has become available and will also be utilized for training (Weinstein et al.,
2013). Expression measurements from each RNA-seq dataset is summarized in terms of
Fragments Per Kilobase of transcript per Million mapped reads (FPKM), a measurement
that accounts for both transcript length and the number of mapped reads within a sample
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(Trapnell et al., 2010). This allows for easier comparison of expression measurements across
genes and samples within an RNA-seq study. More modern RNA-seq measurements, such
as Transcripts Per Million (TPM, Patro et al. (2017)) may also be utilized but were not
available from Moffitt et al. (2015). Basic information regarding each dataset is provided
in Table 1. Each microarray dataset was normalized as described in Moffitt et al. (2015).
We wish to harness the above datasets to select gene signatures that are predictive
of the basal-like subtype. However, the datasets arise from various expression platforms
and therefore have different scales for their expression measurements. Furthermore, the
datasets have been separately pre-normalized. For these reasons, external validation and
comparison of basal-like subtype prediction models trained separately on each dataset is
challenging. In addition, integrating datasets to train a single prediction model and select
study-consistent variables is difficult, given various expression platforms and states of pre-
processing. The between-study heterogeneity in gene effects may also impact the selection
and estimation of study-consistent variables for subtype prediction.
Motivated by these issues, we propose a novel data integration approach to facilitate
between-study comparisons and merging of samples in Section 3. We also introduce a
high dimensional pGLMM to select variables that are study-consistent while accounting
for between-study heterogeneity in their effects. We compare our method with several
common strategies for gene signature selection and subtype prediction using the data in
Table 1, and summarize the results in Section 7.
Dataset Platform Sample Size Gene Set Size % of Basal-like Pre-normalized?
UNC PDAC Microarray 228 19749 40% Yes
UNC Breast Cancer Microarray 337 17631 26% Yes
TCGA Bladder Cancer RNA-seq 223 20533 47% No
TCGA PDAC RNA-seq 150 20531 43% No
Table 1: Summaries of four gene expression datasets with basal-like subtype
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3 Methods
We consider integrating data from K independent studies. For simplicity, we assume there
are n subjects in each study and the total sample size N = nK. In the k-th study for
k = 1, . . . , K, let yk = (yk1, . . . , ykn)
T be the vector of n independent responses, xki =
(xki,1, . . . , xki,pn)
T be the pn-dimensional vector of predictors, and Xk = (xk1, . . . ,xkn)
T .
Suppose the conditional distribution of yk given Xk belongs to the canonical exponential
family, having the following density function up to an affine transformation that
f(yk|Xk,αk;θ) =
n∏
i=1
c(yki) exp
[
τ−1{ykiϑki − b(ϑki)}
]
, (1)
where c(yki) is a constant that only depends on yki, τ is the dispersion parameter, b(·) is a
known link function, and the linear predictor
ϑki = x
T
kiβ + z
T
kiΓαk, (2)
such that β = (β1, . . . , βpn)
T is the pn-dimensional vector of fixed effects, αk is the qn-
dimensional vector of unobservable random effects, zki is a qn-dimensional subvector of xki,
and Γ is a lower triangular matrix. We assume {αk}Kk=1 are independent and identically
distributed from a general distribution with density φ(αk). A common choice of φ(αk) is
the multivariate normal distribution N(0, Iqn×qn) and Γαk ∼ N(0,ΓΓT ). In addition, we
assume that E(αk) = 0 and Var(αk) = Iqn . The random component in the linear predictor
has Var(Γαk) = ΓΓ
T . We allow some rows of Γ to be identically zero, which implies that
the effects of corresponding covariates are fixed across the K studies. We consider the high
dimensional setting for which pn  n, qn  n, and they both can grow with n. We use
the subscript n to denote such a dependence on n.
Similar to Chen and Dunson (2003) and Ibrahim et al. (2011), we reparameterize the
linear predictor as
ϑki = x
T
kiβ + z
T
kiΓαk =
(
xTki (αk ⊗ zki)TJq
)β
γ
 , (3)
where γt is a t × 1 vector consisting of nonzero elements of the t-th row of Γ, γ =
(γT1 , . . . ,γ
T
qn)
T , and Jqn is the q
2
n × qn(qn + 1)/2 matrix that transforms γ to vec(Γ), i.e.
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vec(Γ) = Jqnγ. We define the vector of parameters θ = (β
T ,γT , τ)T and assume the true
value of θ is θ∗ = (β∗T ,γ∗T , τ ∗)T such that θ∗ = argminθ E[−`(θ)], where `(θ) is the total
log-likelihood from the K studies. While the linear predictor ϑki is indeed a function of the
parameter θ, we suppress its dependence on θ for the sake of notational simplicity. In ad-
dition, we abbreviate ϑki(θ
∗) as ϑ∗ki, the value of the linear predictor when the parameters
are taken at their true values. As proposed in the above, we would like to identify the set
S = S1 ∪ S2 = {j : β∗j 6= 0} ∪ {t : ‖γ∗t‖2 6= 0}.
Let s1n = |{j : β∗j 6= 0}| be the cardinality of set S1, s2n =
∑
t:‖γ∗t ‖2 6=0 t be the cardinality of
set S2, sn = s1n + s2n, and dn = pn + qn(qn + 1)/2 be the dimension of the whole problem.
In this paper, we consider the case that dn, pn, qn, and sn change with sample size n, but
K remains fixed.
In order to recover the set S, we propose to solve the following penalized likelihood
problem:
θ̂ = argmin
θ
− `(θ) + λ1
pn∑
j=1
ρ1(βj) + λ2
qn∑
t=1
ρ2(‖γt‖2), (4)
where `(θ) =
∑K
k=1 `k(θ), `k(θ) is the observed log-likelihood from the k-th dataset such
that `k(θ) = (1/n) log
∫
f(yk|Xk,αk;θ)φ(αk)dαk, ρ1(t) and ρ2(t) are some penalty func-
tions, and λ1 and λ2 are positive tuning parameters. Since (4) is a likelihood based method,
we may allow the responses {yk}Kk=1 to be of different types. We choose ρ1(t) and ρ2(t)
as general folded-concave penalty functions that satisfy condition 8 in Lemma 1 in the
Supplementary Material. Examples of such functions include the L1 penalty, the SCAD
penalty (Fan and Li, 2001) and the MCP penalty (Zhang, 2010). The penalization on γ
is done in a groupwise manner (Yuan and Lin, 2006), namely we regard elements in γt
as a group and penalize its L2-norm. Elements of the corresponding estimator γ̂t will be
either all zero or all nonzero. If γ̂t = 0, the corresponding variable’s effect is regarded
as fixed across studies. The selection of such variables (i.e. S2) enables us to determine
which predictors have non-zero fixed effects. We postulate that accounting for study-level
heterogeneity will reduce the bias in fixed effects estimates.
In most applications, we recommend setting pn = qn and let the algorithm determine
which variables should be regarded as fixed effects. However, if we know that some variables
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can be treated as fixed effects based on prior knowledge, we only need to impose the penalty
ρ2 on the other variables. Based on selections in S, we only use predictors with nonzero
fixed effects for prediction.
Compared to the existing literature on pGLMMs (Bondell et al., 2010; Ibrahim et al.,
2011), our paper is new in the following perspectives. First, we deal with a much larger
dimension compared to existing articles. In our application, pn and qn can both be greater
than 50, yielding at least 2100 possible models to be chosen from, whereas the existing
articles only consider pn = 7 and qn = 3 in Ibrahim et al. (2011) and pn = qn = 16 in
Bondell et al. (2010). In particular, large values of qn increase the computational complexity
of the problem, as the likelihood in (4) involves an integral of dimension qn. To solve such a
large-scale problem, a new algorithm is developed to estimate the pGLMM. More details are
given in Section 4. In addition, we give a high-dimensional asymptotic result in Theorem 1
allowing both pn and qn diverge with n, while the theory in Ibrahim et al. (2011) requires
pn and qn to be fixed.
Next, we introduce a technique to facilitate data integration over different studies. The
motivation is that even though the raw values of gene expression may be on different scales
in different studies, their relative magnitudes can be preserved by ranks. Therefore, we
propose to use some rank-derived quantities as predictors in models (1) and (2), instead
of the raw values. We use a variant of the Top Scoring Pair (TSP) approach (Leek, 2009;
Patil et al., 2015; Afsari et al., 2015).
Suppose there are G common genes in all K studies. We enumerate G(G − 1)/2 gene
pairs (gki,s, gki,t), where gki,s is the raw expression of gene s for subject i in study k and gki,t
is defined similarly. For each gene pair (gki,s, gki,t), the TSP is an indicator I(gki,s > gki,t)
representing which gene of the two has higher expression in subject i. Such binary indicators
are then used as the predictors in (1) and (2). In other words, xki consists of G(G− 1)/2
binary variables.
We view such binary variables as “biological switches” indicating how pairs of genes are
expressed relative to some clinical outcome. TSPs were originally proposed in the context
of binary classification (Afsari et al., 2014). We find that this representation of the original
data is also appealing for integrative analysis. First, the TSP only depends on the ranks
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of raw gene expression in a sample. Hence, it is invariant to monotone transformations
of raw values. As a result, it is less sensitive to various normalization procedures of data
pre-processing. (Afsari et al., 2014; Patil et al., 2015; Leek, 2009). Second, it simplifies
data integration over different studies. The raw gene expression values may not be directly
comparable. After converting them into binary scores, data from different studies can
be pooled together without the need for between-sample or cross-study normalization.
Prediction in new patients is also simplified, as normalizing new patient data to the training
set is no longer necessary.
In general, we wish to select gene pairs that are consistent in their relationship with
subtypes across multiple studies. An ideal gene pair is such that one gene in the pair
has higher expression than the other gene in one subtype, lower expression in the other
subtype, and has this flip replicated across many subjects. Each gene in the pair should
ideally be differentially expressed between subtypes. Such ideal gene pairs are less likely to
be observed purely due to technical biases, as this flip in expression is specific to subtype
and is also replicated across many subjects. Indeed, many recent publications utilizing
gene pair-based approaches have shown high accuracy and robustness in their validation
datasets, reflecting this point (Afsari et al., 2015; Shen et al., 2017; Afsari et al., 2014;
Leek, 2009; Kagaris et al., 2018; Patil et al., 2015).
However, some care needs to be taken when merging gene pairs generated from differ-
ent platforms, especially when merging microarray data with data from other platforms
such as RNA-seq. For microarrays, it is known that differences in absolute expression be-
tween certain genes may not correlate with differences in measured probe-level expression.
Therefore, merging microarray data with other platforms may reduce the sensitivity to
detect such ideal gene pairs. As a result, our gene-pair approach is more applicable when
data come from the same or similar platforms. It is also preferable to utilize more modern
expression platforms (such as RNA-seq), as well techniques that correct for GC content
and other biases in gene expression measurement (Patro et al., 2017), as these approaches
may improve the correlation between measured and true expression of genes. Lastly, our
gene pair approach is predicated on the fact that the genes must also have overlapping
expression ranges. This is commonly observed in our real data application candidate gene
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set, but may not always be the case. When the expression ranges of two genes do not
overlap, the corresponding TSP will not flip with respect to subtype across patients, and
would therefore would be uninformative for prediction.
4 MCECM Algorithm
Since the observed likelihood involves intractable integrals, we utilize a Monte Carlo Ex-
pectation Conditional Minimization (MCECM) algorithm for solving (4) (Garcia et al.,
2010). Denote the complete and the observed data for study k by dk,c = (yk,Xk,αk) and
dk,o = (yki,xki), respectively, and the entire complete and observed data by dc and do,
respectively. Let λ = (λ1, λ2). At the s-th iteration, given θ
(s), the E-step is to evaluate
the penalized Q-function, given by
Qλ(θ|θ(s)) =
K∑
k=1
E
{
− log(f(dk,c;θ|do;θ(s)))
}
+ λ1
pn∑
j=1
ρ1(βj) + λ2
qn∑
t=1
ρ2(‖γt‖2) (5)
= Q1(θ|θ(s)) + λ1
pn∑
j=1
ρ1(βj) + λ2
qn∑
t=1
ρ2(‖γt‖2) +Q2(θ(s)), (6)
where dk,c = (yk,Xk,αk), and
Q1(θ|θ(s)) = −
K∑
k=1
∫
log f(yk|Xk,αk;θ)φ(αk|do,k;θ(s))dαk,
Q2(θ
(s)) = −
K∑
k=1
∫
log φ(αk)φ(αk|do,k;θ(s))dαk.
Because these integrals are often intractable, we approximate these integrals by taking
a Markov Chain Monte Carlo sample of size L from the density φ(αk|do,k;θ(s)) using a
coordinate-wise metropolis algorithm described in McCulloch (1997) with standard normal
candidate distribution. This leads to a more efficient performance for larger qn. Let α
(s,l)
k
be the l-th simulated value, for l = 1, . . . , L, at the s-th iteration of the algorithm. The
integral in (6) can be approximated as
Q1(θ|θ(s)) = − 1
L
L∑
l=1
K∑
k=1
log f(yk|Xk,α(s,l)k ;θ),
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Q2(θ
(s)) = − 1
L
L∑
l=1
K∑
k=1
log φ(α
(s,l)
k ).
The M-step involves minimizing
Q1,λ(θ|θ(s)) = Q1(θ|θ(s)) + λ1
pn∑
j=1
ρ1(βj) + λ2
qn∑
t=1
ρ2(‖γt‖2)
with respect to θ = (β,γ, τ). Minimizing Q1,λ(θ|θ(s)) with respect to τ is straightforward
and can be done using a standard optimization algorithm, such as the Newton-Raphson
Algorithm (Rashid et al., 2014). Minimizing Q1,λ with respect to β and γ is done via
the coordinate gradient descent algorithm, leading to more efficient performance in larger
dimensions.
In particular, we utilize three conditional minimization steps. Prior to minimization,
we augment the matrices used in the linear predictor by “filling in” the missing values of
αk with α
(s,l)
k , repeating the rows of the original matrices L times and replacing αk with
α
(s,l)
k in each of the L repeated rows. This leaves us with Z˜nKL×q(q−1)/2 =
(
z˜T11, . . . , z˜
T
nK
)T
,
where z˜ki = (α˜k ⊗ zki)TJq, and α˜k = ((α(s,1)k )T , . . . , (α(s,L)k )T )T , as well as X˜nKL×pn =
(x˜T11, . . . , x˜
T
nK)
T to match the dimension of Z˜, where x˜ki = xkiJL×1. We first minimize Q1,λ
with respect to β given γ(s) and τ (s) to obtain β(s+1) using the coordinate gradient descent
approach similar to Breheny and Huang (2011) with predictor matrix X˜ and offset Z˜γ(s).
We then minimize Q1,λ with respect to γ given β
(s+1) and τ (s) to obtain γ(s+1) using the
blockwise gradient descent algorithm (Breheny and Huang, 2015) with X˜β(s+1) serving as
an offset. Therefore, elements of the corresponding estimator γ̂t will be either all zero or
all nonzero. If γ̂t = 0, the t-th predictor will be regarded as fixed effect. By separating
the penalized estimation of β and γ into two conditional minimization steps, we are able
to simplify the variable selection process into a standard variable selection problem for
β and a group variable selection problem for γ. Lastly, we minimize Q1,λ with respect
to τ given β(s+1) and γ(s+1) to obtain τ (s+1). This minimization is performed using the
Newton-Raphson algorithm.
As qn increases, the dimension of γ also increases. We utilize an approximation treating
the covariance matrix ΓΓT as a diagonal matrix. This approach has been demonstrated to
be advantageous for high-dimensional mixed models (Fan and Li, 2012), and also results
in greater computational efficiency. This is because the accumulative estimation error in
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estimating the full covariance matrix for large qn can be much larger than the bias incurred
from utilizing a diagonal covariance matrix.
To ensure that the estimator θ̂ has good properties, the penalty parameter λ has to
be appropriately selected. Two common criteria are generalized cross validation and BIC
(Wang et al., 2007). However, these criteria cannot be easily computed in the presence
of random effects, because they are functions of the observed likelihood, which involves
intractable integrals. Moreover, it has been shown in Wang et al. (2007) that even in
the simple linear model, the generalized cross validation criterion can lead to significant
overfitting. Instead, we utilize the ICQ criterion (Ibrahim et al., 2011) to select the optimal
λ by minimizing
ICQ(λ) = 2Q(θ̂λ|θ̂0) + cN(θ̂λ)
where cN(θ̂λ) = dim(θ) × log(N), Q(θ̂λ|θ̂0) = Q1(θ̂λ|θ̂0) + Q2(θ̂0), θ̂0 is the estimator of
θ from the full model, and θ̂λ is the estimator from the model fitted with a particular λ.
As in the EM algorithm, we can draw a set of samples from f(αk|dk,o; θ̂0) for k = 1, . . . , K
to estimate Q(θ̂λ|θ̂0) for any λ. In higher dimensions, we choose small values for λ1 and
λ2 to approximate θ̂0. Given the ICQ criterion, we perform a grid search of (λ1, λ2) to find
the optimal values.
For the penalty functions, we consider the MCP penalty for both ρ1(t) and ρ2(t), which
is defined as ρ(t) = λt − t2/(2ω) for t ≤ ωλ and ρ(t) = 0 for t > ωλ. Similar to Breheny
and Huang (2011), we choose ω = 3. Other penalties such as the SCAD and the L1
penalties may be utilized. Given the promising performance of the MCP penalty in previous
publications, we do not explicitly compare between penalties in this paper.
5 Theory
We first introduce some notation. For two sequences an and bn, we write an = o(bn) if
an/bn → 0; an  bn if bn = o(an); an = O(bn) if an ≤ cbn for some positive constant c. For
a p-dimensional vector a, let ‖a‖∞ = max1≤j≤p |aj| denote its sup-norm. Let aS be a sub-
vector of a with indices in the set S. For a p×p matrix A, let ‖A‖∞ = max1≤i≤p
∑p
j=1 |aij|
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denote the matrix sup-norm. Denote bn = (min1≤j≤pn{|β∗j |} ∧ min1≤t≤qn{‖γ∗t‖2})/2. Let
λln = min{λ1, λ2} and λun = max{λ1, λ2}. For simplicity, we assume the dispersion param-
eter τ = 1 and ρ1(t) = ρ2(t) = ρ(t). We define the local concavity of the penalty function
as
κ(ρ,u) = lim
ε→0+
max
1≤j≤sn
sup
t1<t2∈(|uj |−ε,|uj |+ε)
−ρ
′(t2)− ρ′(t1)
t2 − t1 .
We define a neighborhood of θ∗ as N = {θ = (βT ,γT )T : ‖βS1 − β∗S1‖∞ ≤ cn, ‖γS2 −
γ∗S2‖∞ ≤ cn,βSc1 = 0, and γSc2 = 0}, where cn = cn−δ for some c > 0, 0 < δ < 1/2,
Sc1 = {1, . . . , pn}\S1, and Sc2 = {1, . . . , qn(1 + qn)/2}\S2.
The main result in Theorem 1 implies that the estimator θ̂ asymptotically recovers S
and gives a uniform consistent estimator of θ∗S.
Theorem 1. Assume conditions (C1)-(C8) as shown in the Supplementary Material hold.
If λunρ
′(bn) = o(n−δ), λln  nξ(s3/2n bn/
√
n +
√
(log dn)/n + snn
−2δ) for 0 < ξ < 1/2 and
λunκ0n = o(τ0n), where κ0n = supu∈N0 κ(ρ,u), N0 = {θS ∈ Rsn : ‖θS − θ∗S‖∞ ≤ cn}, and
τ0n = minθ∈N λmin(∇2θS`(θ)), there exists a sufficiently large positive constant C such that
with probability greater than 1−Ksnn−C −K(dn − sn)d−Cn , it holds that
(a) {j : θ̂j 6= 0} = {j : θ∗j 6= 0}.
(b) ‖θ̂S − θ∗S‖∞ = O(n−δ), where 0 < δ < 1/2.
The convergence rate δ in statement (b) depends on the minimal signal bn, the dimen-
sionality dn, the sparsity measurement sn and the penalty function ρ(·). In general, the
larger bn is and the smaller dn and sn are, the faster θ̂ converges. The optimal rate can be
as close as a root-n rate.
In Theorem 1, it is feasible to choose proper tuning parameters λ1 and λ2 to satisfy all
requirements. For example, if the L1 penalty is used, and we assume bn is bounded away
from 0, we only need to choose λ1 and λ2 such that λun = o(n
−δ) for some 0 < δ < 1/2
and λln  s3/2n /
√
n+
√
(log dn)/n. As long as sn = o(
√
n) and log(dn) = o(n), there exists
a feasible region for λ1 and λ2. In practice, we tune the optimal λ1 and λ2 using methods
described in Section 4.
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6 Simulation Studies
6.1 Oracle setting
We first examine the oracle setting where the variables relevant to the outcome are known
apriori. We demonstrate the performance of our method in comparison to some common
strategies to estimate variable effects from multiple datasets. The first strategy is the tra-
ditional study-by-study analysis approach, where variable effects are estimated separately
in each individual study. The second strategy is to combine samples from all studies into
a single dataset, and then estimate variable effects in a single model. We define a third
strategy as a GLMM applied to the merged data, assuming no penalization on the fixed
and random effects. To mimic the process of external validation, we utilize the fitted model
from each strategy to predict outcomes in an externally simulated dataset. The median ab-
solute prediction error is calculated for each strategy, and is then averaged over simulations.
We assess each strategy’s performance in terms of the bias of the estimated coefficients as
well as the prediction accuracy under external validation. We will later examine the vari-
able selection performance under similar conditions when the set of relevant variables is
unknown apriori.
Specifically, we generate binary responses representing cancer subtype from a ran-
dom effects logistic regression model with two predictors and an intercept. A range of
sample sizes, number of studies, magnitudes of variable effects, and levels of between-
study heterogeneity are to be inspected. For study k, we generate the binary response
yki, i = 1, . . . , nk such that yki ∼ Be(pki) where pki = P (yki = 1|xki, zki,αk,β∗) =
exp(xTkiβ
∗ + zTkiαk)/{1 + exp(xTkiβ∗ + zTkiαk)}, and αk ∼ N3(0, σ2I), where σ2 controls
between-study heterogeneity. To simulate imbalanced sample sizes, we allocate N/3 sam-
ples to study k = 1 and evenly distribute the remaining 2N/3 samples to the remain-
ing studies. We perform simulations for N = 100, 500, K = 2, 5, 10, σ2 = 0.5, 1, 2,
β∗ = (β∗0 , β
∗
1 , β
∗
2)
T = (0, 1, 1)T for moderate predictor effect, and β∗ = (0, 2, 2)T for strong
predictor effect. For each k, we denote the vector of predictors pertaining to subject i as
xki = (1, xki,1, xki,2)
T , where we assume xki,j ∼ N(0, 1), j = 1, 2. We also assume a random
intercept and random slope for each predictor by setting zki = xki. The external validation
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set of 100 samples is generated under the same conditions as the training set to produce
ynew,i and xnew,i.
For the first strategy (IND), we apply a logistic regression model to each of the K
datasets and calculate p̂new,i, the predicted probability of ynew,i = 1, using xnew,i and
the estimated coefficients from each model. For the second strategy (GLM), we apply a
logistic regression model to the merged dataset to obtain p̂new,i. For our method (GLMM),
we apply a random effects logistic regression model to the merged dataset to obtain the
estimated fixed effect coefficients, assuming a random slope for each predictor. Here, only
the estimated fixed effect coefficients are used to obtain p̂new,i. In all of the above regression
models, we assume the relevant predictors are known to us and only use them in the
model. The median absolute prediction error for each strategy is calculated as PEmed =
median(|ynew,i − p̂new,i|), where i varies in the validation set. For the first strategy, PEmed
is averaged across the K studies.
We first illustrate the results of a single simulation in Figure 1. In this scenario, we
simulate five studies of a total of 500 samples assuming moderate variable effects and high
between-study heterogeneity, i.e., we choose N = 500, K = 5, β∗ = (0, 1, 1)T , σ2 = 2.
Applying the first strategy to the data illustrates the significant study-to-study variation
in the estimated coefficients (Figure 1, left panel). This variation is also observed for the
study-level absolute prediction errors in the simulated external validation set (Figure 1,
right panel). In this setting, researchers using Study 3 would estimate a strong association
between each predictor and the response, and may further conclude that their model per-
forms well in the validation set. However, researchers using Study 1 may conclude otherwise
due to the between-study heterogeneity in variable effects. Combining data in the second
strategy results in smaller prediction errors compared with the first strategy. This obser-
vation is in line with the prior findings suggesting that combining data results in better
estimation and prediction (Waldron et al., 2014). However, accounting for heterogeneity
further improves the median absolute prediction error.
Our full simulation results are presented in Tables 2 and 3, where we average results over
100 simulations per condition. Several trends are apparent from these results, reflecting
our illustration from Figure 1. First, combining data from multiple studies results in an
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reduction of the median absolute prediction error (PEGLMMmed , PE
GLM
med ) compared with
models trained on individual studies (PEINDmed ); see Table 2. We also find that the relative
prediction accuracy of the GLMM improves more when the simulated heterogeneity σ2 and
the number of studies K increase. This is due to an increased bias by the GLM when σ2
and K increase. Also, differences in prediction accuracy between the two strategies become
more apparent as the strength of the predictor effects increases (Table 3). Lastly, the bias
of the estimated coefficients by the GLMM decreases as K and N increase, as more data
are available to estimate β and Γ. In all, combining datasets in strategies two and three
leads to better prediction accuracy and accounting for between-study heterogeneity via our
method further improves the performance.
These observations show that even in the oracle setting where the relevant predictors
are known, accounting between-study heterogeneity has important consequences in model
estimation and prediction. We assume in our simulations that the training and validation
sets are generated from the same population. We show that even without other complicat-
ing factors, between-study heterogeneity can still impact the accuracy and replicability of
common approaches such as strategies one and two. While we utilize normally-distributed
predictors in our simulations, the impact of between-study heterogeneity will generally ap-
ply to variables from any distribution. In the next section, we show that heterogeneity
presents additional problems in variable selection when important variables are unknown.
6.2 Non-oracle setting
We again assume that only two variables are relevant to the outcome, but now are unknown
apriori. We aim to select these variables from a set of p variables and utilize them to predict
outcomes in an external dataset. In our simulation, we assume the effects of the remaining
p−2 variables are zero in all studies. We simulate our data the same way as in the previous
section, except we now generate xki,j ∼ N(0, 1), j = 1, . . . p. We assume xki = zki. We
consider p = 10 or 50, N = 500, and K = 5 or 10. Simulation results for these scenarios
are given in Tables 4 and 5.
We examine three strategies for selecting and estimating the effects of the relevant
variables. For the first strategy (IND), we apply a penalized logistic regression model
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N K σ2 β̂GLMM1 β̂
GLMM
2 β̂
GLM
1 β̂
GLM
2 PE
GLMM
med PE
GLM
med PE
IND
med
100 2 0.5 1.03 1.06 0.90 1.03 0.33 0.34 0.39
1 1.11 1.06 0.84 0.81 0.38 0.40 0.43
2 1.01 0.97 0.76 0.49 0.42 0.43 0.46
5 0.5 1.14 1.15 0.95 0.93 0.34 0.35 0.39
1 1.12 0.98 0.77 0.74 0.40 0.42 0.43
2 1.22 1.06 0.53 0.49 0.45 0.47 0.48
10 0.5 1.15 1.20 0.93 0.96 0.33 0.35 0.39
1 1.07 1.01 0.73 0.67 0.38 0.41 0.43
2 1.02 0.87 0.40 0.40 0.43 0.47 0.47
500 2 0.5 1.05 1.00 1.01 0.95 0.35 0.36 0.39
1 0.93 1.03 0.82 0.79 0.39 0.42 0.43
2 0.90 0.79 0.63 0.55 0.44 0.46 0.47
5 0.5 0.99 1.04 0.89 0.90 0.33 0.36 0.41
1 0.99 0.93 0.73 0.63 0.36 0.41 0.44
2 0.94 0.92 0.41 0.40 0.42 0.47 0.48
10 0.5 0.99 1.04 0.90 0.94 0.34 0.36 0.39
1 1.09 0.99 0.77 0.69 0.37 0.40 0.42
2 0.94 0.97 0.49 0.47 0.43 0.47 0.47
Table 2: Estimation and prediction under the oracle setting with moderate variable effects
for β∗ = (β∗0 , β
∗
1 , β
∗
2)
T = (0, 1, 1)T .
N K σ2 β̂GLMM1 β̂
GLMM
2 β̂
GLM
1 β̂
GLM
2 PE
GLMM
med PE
GLM
med PE
IND
med
100 2 0.5 2.11 2.09 1.96 1.88 0.14 0.16 0.26
1 2.22 2.11 1.72 1.65 0.16 0.21 0.30
2 1.79 2.30 1.08 1.28 0.30 0.35 0.41
5 0.5 2.18 2.31 1.89 1.98 0.16 0.17 0.26
1 2.12 2.21 1.52 1.47 0.19 0.22 0.31
2 1.91 1.92 0.85 0.85 0.27 0.32 0.38
10 0.5 2.25 2.31 1.88 1.86 0.13 0.17 0.26
1 2.07 2.26 1.39 1.51 0.17 0.24 0.32
2 2.26 2.12 0.98 0.77 0.28 0.38 0.40
500 2 0.5 2.04 1.98 1.97 1.93 0.15 0.17 0.26
1 1.93 1.95 1.66 1.60 0.20 0.26 0.32
2 2.10 1.96 1.54 1.18 0.26 0.36 0.39
5 0.5 2.09 2.00 1.92 1.85 0.12 0.16 0.29
1 2.02 1.89 1.54 1.44 0.18 0.25 0.36
2 1.88 1.89 0.89 0.87 0.25 0.36 0.41
10 0.5 2.01 1.98 1.85 1.85 0.15 0.17 0.26
1 1.93 1.91 1.41 1.40 0.18 0.25 0.31
2 1.81 1.83 0.88 0.90 0.27 0.36 0.40
Table 3: Estimation and prediction under the oracle setting with strong variable effects for
β∗ = (β∗0 , β
∗
1 , β
∗
2)
T = (0, 2, 2)T .
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(a)
(b)
Figure 1: Estimation and prediction for strategies 1–3 for a single simulation (N = 500,
K = 5, β∗0 = 0, β
∗
1 = β
∗
2 = 1, σ
2 = 2) under the oracle setting. (a) Estimated coefficients
in each of the five simulated training datasets. (b) Boxplots of the prediction errors in a
simulated external validation set. Colored boxplots correspond to the predictions given by
the study-by-study analysis.
18
separately in each study to select relevant variables. For the second strategy (GLM), we
merge samples from all studies, and then apply the penalized logistic regression to select
relevant variables. Lastly, we apply our method (GLMM) to the merged dataset. The BIC
is used to select the optimal tuning parameters for the first two methods. The optimal
tuning parameters of our method are obtained via a grid search based on the ICQ. In all
methods, we choose the MCP penalty. Two metrics assessing variable selection performance
are presented in Tables 4 and 5. We denote TP as the true positives, i.e., the number of
correctly selected variables with true non-zero effects; and FP as the false positives, i.e.,
the number of incorrectly selected variables with true zero effect.
In the low dimensional setting of p = 10, our method is most advantageous when
the heterogeneity is high and the variables’ effects are moderate (Table 4). In general,
strategy two selects fewer true positives but more false positives compared with our method.
We also find that the first strategy results in the fewest true positives with the greatest
false positives. Its performance worsens when σ2 and K increase. This is due to the
smaller per-study sample size when K increases, as well as the greater chance to have
small simulated effects at larger σ2. Similar to the previous section, we observe that the
first two strategies perform worse than our method in estimation. These results also apply
in the high dimensional setting of p = 50. In this scenario, the FPGLMM is slightly higher
than FPGLM in certain settings. But the GLMM has better sensitivity in selecting true
positives and prediction performance.
Overall, we find that combining datasets improves the variable selection compared with
the study-by-study analysis. We also find that accounting for heterogeneity in our method
can further improve variable selection, reduce bias, and reduce prediction error. In the non-
oracle setting where the relevant variables are unknown, the prediction errors are generally
larger than the ones in the oracle case. This is due to the uncertainty of variable selection
as well as the bias introduced by penalization.
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N p K σ2 β̂GLMM1 β̂
GLMM
2 β̂
GLM
1 β̂
GLM
2 TP
GLMM FPGLMM TPGLM FPGLM TP IND FP IND PEGLMMmed PE
GLM
med PE
IND
med
500 10 5 1 0.96 1.05 0.63 0.68 1.80 0.14 1.75 0.34 0.54 1.40 0.39 0.42 0.44
2 1.16 1.33 0.60 0.57 1.44 0.15 1.34 0.27 0.49 1.40 0.45 0.48 0.48
10 1 0.99 0.89 0.67 0.67 1.96 0.14 1.81 0.39 0.16 1.10 0.37 0.42 0.45
2 1.11 1.20 0.39 0.57 1.71 0.13 1.53 0.26 0.11 1.20 0.45 0.47 0.49
500 50 5 1 1.18 1.15 0.45 0.47 1.82 0.57 1.61 0.61 0.2 0.3 0.36 0.44 0.42
2 1.12 1.18 0.55 0.44 1.47 0.91 1.12 0.42 0.23 1.4 0.36 0.43 0.44
10 1 1.18 1.14 0.48 0.48 1.86 0.72 1.38 0.92 0.15 1.3 0.31 0.42 0.42
2 1.23 1.38 0.55 0.53 1.51 1.08 1.23 0.4 0.13 1.3 0.36 0.41 0.43
Table 4: Variable selection, estimation and prediction under the non-oracle setting with
moderate variable effects for β∗ = (β∗0 , β
∗
1 , β
∗
2)
T = (0, 1, 1)T .
N p K σ2 β̂GLMM1 β̂
GLMM
2 β̂
GLM
1 β̂
GLM
2 TP
GLMM FPGLMM TPGLM FPGLM TP IND FP IND PEGLMMmed PE
GLM
med PE
IND
med
500 10 5 1 1.94 1.93 1.48 1.45 2.00 0.07 2.00 0.11 0.40 2.00 0.19 0.25 0.33
2 2.00 2.16 1.08 1.07 1.88 0.08 1.78 0.15 0.34 2.00 0.24 0.35 0.39
10 1 1.90 1.90 1.42 1.36 2.00 0.08 2.00 0.10 0.34 0.80 0.18 0.25 0.39
2 1.83 2.00 0.95 0.94 1.97 0.11 1.80 0.23 0.22 0.90 0.28 0.39 0.44
500 50 5 1 2.19 2.04 1.48 1.53 2.00 0.84 1.58 1.62 0.00 0.00 0.18 0.3 0.37
2 2.13 1.93 1.16 0.87 1.94 2.4 1.45 1.28 0.18 1.8 0.27 0.41 0.42
10 1 2.09 2.16 1.46 1.49 2.00 1.36 1.28 2.84 0.3 0.2 0.16 0.34 0.4
2 2.27 2.32 0.83 0.89 1.97 1.75 1.25 2.71 0.11 1.3 0.23 0.43 0.43
Table 5: Variable selection, estimation and prediction under the non-oracle setting with
strong variable effects for β∗ = (β∗0 , β
∗
1 , β
∗
2)
T = (0, 2, 2)T .
7 Improved Clinical Subtype Prediction in Pancreatic
Cancer via Horizontal Data Integration
Using our described data integration approach, we apply four methods to the four datasets
described in Table 1 to predict the ‘basal-like’ subtype in new pancreatic cancer patients.
We will show that our method results in better prediction relative to the other methods in
the presence of between-study heterogeneity.
To generate the predictors, we first use 302 genes that were deemed to be tumor-
specific in Moffitt et al. (2015) and appear in all four studies. Then, we apply the rank
transformation described in Section 2 in each dataset, enumerating all possible 45,451 TSPs
based on these common genes. To reduce the dimension, we further screen these TSPs by
applying a univariate random effects logistic regression model with respect to each TSP,
assuming a random slope and a random intercept. We sort the TSPs from largest to
the smallest by the marginal likelihood from their corresponding random effects logistic
regression model. Then, similar to Afsari et al. (2015), we keep TSPs with larger marginal
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likelihood and remove TSPs sharing one gene with the higher ranked ones. This reduces
potential strong correlation between TSPs sharing same genes (Supplementary Figure 1).
After screening, 95 TSPs remain, of which we select the top 50 ones to be used as covariates
in the regression model. We aim to determine the best subset of the 50 TSPs for prediction.
This results in a total of 250 possible fixed effects models and 2100 possible random effects
models.
In Figure 2, we represent the top 50 TSPs for each sample in the four studies. Yellow
cells indicate that the first gene in the TSP has higher expression than the second gene and
the red ones indicate otherwise. It is clear that certain TSPs have variable association with
the subtype across studies, i.e., low replicability. Our goal is to select the TSPs that are
consistently associated with the subtype across studies while accounting for between-study
heterogeneity.
We compare four methods. For the first method, we apply the penalized logistic regres-
sion model (pGLM) to each dataset. For the second method, we combine all datasets and
run the penalized logistic regression model (pGLMC). For the third method, we run the
penalized logistic regression model with random effects on the combined data (pGLMMC).
Finally, we run the Meta-Lasso method (Li et al., 2014) on the combined data. For each
subject, we assume the response yki = 1 if the subject is of the basal-like subtype and 0
otherwise. The vector xki is the vector of the screened TSPs as shown in Figure 2. The
computational details of the first three methods is the same as described in the simulation
study. For the Meta-Lasso method, the coefficients pertaining to the same TSP in multiple
studies are treated as a group and the composite group penalty is imposed on each group
as in Li et al. (2014), to select the key TSPs. The TSPs selected by Meta-Lasso are defined
as the ones that have non-zero estimated coefficients in at least one study. The optimal
tuning parameters in Meta-Lasso is determined by the BIC method described in Li et al.
(2014).
The selected TSPs by the four methods are shown in Figure 3. Not surprisingly, for the
pGLM, very different TSPs are selected in different studies. We find that TSPs that are
repeatedly selected by the pGLM are also more likely to be selected by the pGLMC. Our
method yields larger estimated coefficients than the pGLMC, especially for those TSPs
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Figure 2: The Matrix of screened TSPs in all studies. TSPs are labeled in each row as
“A B”, where “A” indicates the name of gene A and “B” indicates the name of gene B in
the TSP. Columns indicate samples. Yellow cells in a column indicate that the expression
of gene A is greater than the expression of gene B, and red cells indicate otherwise. The
top track (red, green, cyan and purple) indicates study membership. The second track
indicates patient subtype (blue for basal-like and orange for classical). Values of TSPs
vary significantly across studies, where some segregate strongly between basal and classical
subtypes in one study but not in other studies.
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selected by both methods (Figure 4). This mimics findings in our simulation studies that
the estimated coefficients given by the pGLMC are biased in the presence of heterogeneity.
Moreover, the Meta-Lasso selects very different TSPs resulting in poor replicability.
Figure 3: Estimated coefficients given by the four methods.
Next, we evaluate the subtype prediction performance of the four methods. For each
method, we hold one dataset out and train the model using the remaining studies. We
utilize this procedure to mimic the process of external validation. For the pGLM, an
ordinary logistic regression model is fitted to each training study using selected TSPs from
Figure 3. The averages of the three predicted probabilities are assigned to subjects in the
holdout study. Their absolute prediction errors are then calculated and aggregated from
each holdout study. Predictions given by the Meta-Lasso are done similarly using variables
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Figure 4: Estimated coefficients given by the pGLMC and the pGLMMC. Red circles
indicate variables with non-zero random effects estimated by the pGLMMC. Larger red
dots indicate larger estimated between-study variance.
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selected by itself. For the pGLMC and the pGLMMC, a single logistic model is fitted
by combining three training datasets and using their own selected TSPs. The predicted
probabilities are then given by such combined models.
Figure 5 shows the prediction errors given by the four methods in each study. From
its top left panel, we see that the overall performance of the pGLM and the Meta-Lasso
is much worse than the pGLMC and the pGLMMC. These observations reflect the low
replicability of predictions from the pGLM and the Meta-Lasso, as the pGLM does not
borrow strength across datasets and the Meta-Lasso is a method mainly focused on variable
selection. Similar to our simulation studies, our proposed pGLMMC method still performs
well, despite the variation of its prediction errors on the TCGA Bladder Cancer dataset
is larger than that of the pGLMC. Its median prediction error however is still the best in
this study. In addition, as shown in Figure 6, our method is more confident than other
methods for classification as most predicted probabilities are either< 10% for> 90%. In all,
combining datasets significantly improves the prediction accuracy. By taking heterogeneity
into account, our method performs the best out of all competitors.
In the supplementary material, we provide an alternative screening approach that ren-
ders more TSPs and repeat our analysis therein. Our method’s prediction performance
is still much better than the pGLM and the Meta-Lasso, albeit it’s only slightly better
than the pGLMC (Supplementary Figure 6). This is because the between-study hetero-
geneity given by the new screening approach is much smaller than the one shown in this
section. Lastly, we also train our method on the microarray data only and predict on the
RNA-seq data, and vice versa. The prediction performance does not change dramatically
(Supplementary Figure 8).
8 Discussion
In this article, we introduce a novel approach accounting for between-study heterogeneity
in gene signature selection and clinical prediction. We demonstrate through simulations
that approaches ignoring existing between-study heterogeneity have lower prediction accu-
racy, higher bias, and worse variable selection performance than our method. The common
approach of study-by-study analysis shows the worst performance compared with the inte-
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Figure 5: Prediction errors of the holdout studies given by the four methods.
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Figure 6: Predicted probabilities of the basal-like subtype given by the four methods.
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grative approaches. Lastly, we show in a case study of pancreatic cancer that our method
increases prediction accuracy and replicability, where the data integration is facilitated via
a rank-based transformation of the original gene expression data.
These results have some important impact. It is often observed that gene signatures
derived from individual studies demonstrate low replicability, even when they pertain to
similar clinical outcomes. Our simulation results clearly demonstrate that this is partially
due to the heterogeneity among different studies as small sample sizes in individual studies.
We have also shown that as the sample sizes of individual studies decreases, the selection
sensitivity and prediction performance also deteriorate. Selection sensitivity also decreases
when the between-study heterogeneity of a gene’s effect increases. On the other hand, com-
bining data from multiple studies improves variable selection and prediction performance
by borrowing strength across studies. However, without taking between-study heterogene-
ity into account, the naive combination still performs worse than our proposed method. In
the absence of between-study heterogeneity, the random effects model reduces to the fixed
effects model, and therefore we would expect similar performance. This can be observed
in the additional results in the Supplementary Material. Our simulation and case study
results clearly show how the effects of the same variable may vary significantly between
studies, and how this variability impacts prediction. This explains the lack of replicability
observed among published gene signatures.
Finally, we would like to comment that the TSP transformation is one possible way
to enable data integration, and that the choice of the transformation is tangential to the
penalized GLMM model that we have proposed. In addition, the integration of data from
multiple platforms should be taken with care, particularly when merging microarray data
with data from other platforms. Finally, our model aims to select TSPs instead of individual
genes. The success of the TSP transformation relies on the assumption that the raw gene
expression has overlapping ranges. Therefore, as pointed out by one reviewer, it could
be possible that some genes that are differentially expressed between subtypes will not be
selected by our method.
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